The beauty of the next ten years – When a professional event reaches its first decade, it ceases to be a mere occurrence and becomes an indicator. The Cosmetic Executive Women (CEW) France Beauty Day, celebrating its 10th anniversary on June 3rd with an edition dedicated to foresight and innovation,offers precisely this reflection: ten years of technological acceleration, shifts in consumption patterns , and regulatory constraints that have now become structuring forces.
In both the luxury and premium sectors, the "next decade of beauty" is no longer simply about launching a new serum or signing a celebrity spokesperson. It unfolds at the intersection of science (biotech, dermo-cosmetics), data (AI, diagnostics), sustainability (packaging, water, energy), and trust (traceability, evidence of efficacy, safety). Brands must navigate these complexities without losing sight of their core purpose: creating desire while substantiating their promises and securing their value chain.
A CEW France anniversary as a barometer: what foresight really reveals
An anniversary edition focused on the future says a lot about the current state of the industry. For a long time,beauty innovation was associated with sensory experience, storytelling , and image. These dimensions remain vital, especially for premium and luxury brands, but they are no longer sufficient to drive growth. Now, innovation is expected to focus on more "verifiable" aspects: measurable efficacy, safety, ingredient origin, environmental impact, and compatibility with new transparency requirements.
Foresight, in a sector as emotionally charged as beauty, is not simply a projection. It's a method for prioritizing R&D investments , deciding where to invest (laboratories, data, packaging , supply chain), and understanding which expectations will become non-negotiable. Beauty Day thus serves as a credible pretext for mapping the forces at play: the rise of dermo-cosmetics, the growing role of life sciences , the emergence of AI tools in diagnosis and recommendation, and the reinvention of distribution channels.
From promise to proof: effectiveness as a common language
The coming decade will hinge on a simple tension: beauty is a world of desire, but it is increasingly evaluated as a world of results. This doesn't mean that cosmetics are becoming medicine, but rather that the vocabulary and standards are moving closer to evidence-based cultures. The concepts of clinical studies, instrumentation (measuring hydration, elasticity, and pigmentation), and structured consumer panels are gaining ground, even for prestige lines.
This search for evidence is also a response to marketing fatigue. Consumers, bombarded with new product launches, want to understand what justifies the price, the scarcity, or the anti-aging promise. Luxury has an advantage here: its ability to fund laboratories, rely on scientific partners, and produce narratives based on scientific protocols. The challenge is to explain without overwhelming, to make information accessible without diminishing the mystique, and to transform the demonstration into an element of desirability.
In the next ten years, the brands that matter will be those capable of fulfilling a triple commitment: noticeable results, impeccable tolerance (especially for sensitive skin), and communication aligned with claims regulations. This represents a cultural shift: efficacy is no longer just a selling point, it's the very essence of the brand.
Biotech and dermo-cosmetics: when life sciences redesign formulas
Biotech isn't just a buzzword : it refers to the use of living organisms, fermentation, enzymes, or bioengineering to produce active ingredients, often with improved reproducibility and sometimes a reduced environmental impact. Applied to beauty, it promises purer ingredients, supply chains less dependent on seasonality, and the ability to optimize performance. In dermo-cosmetics, the idea is to formulate at the intersection of skincare and dermatology, with a focus on tolerance and the skin barrier.
Fermentation, peptides, ceramides: sophistication becomes invisible
Consumers do expect the promise to be based on a tangible foundation. Peptides, ceramides, stabilized forms of vitamins, and active ingredients derived from fermentation or cell cultures are becoming signature ingredients. Premium brands distinguish themselves less by the sheer number of ingredients than by the relevance of their concentrations, stability, the combination of active ingredients, and the sensory experience, despite their more technically complex formulas.
The microbiome as a horizon, without overpromising
The skin microbiome is emerging as a major area of research: understanding the skin's ecosystem, avoiding its harmful effects, and supporting its balance. It's a promising but delicate field, as the interactions are complex. In the next decade, the winners will be those who avoid over-interpretation and focus on tangible benefits: soothing, reduced redness, improved tolerance to active ingredients, and routines tailored to skin weakened by stress, pollution, or treatments.
For luxury brands, the question is strategic: how to integrate this scientific sophistication while preserving the brand's DNA, the essence of the gesture, the in-salon treatment, and its heritage. The future will be less "techno-demonstrative" than "techno-invisible": science at the service of a seamless experience.
AI and personalization: from diagnosis to formulation, a new care pathway
In the next decade of beauty, artificial intelligence will be more than just a product recommendation tool. It will reshape the skincare journey, from analysis (photos, sensors, questionnaires) to tracking results over time. AI-assisted diagnosis, when properly implemented, can improve the relevance of routines and reduce disappointment from unsuitable purchases. For brands, it's a powerful tool for building loyalty: a customer who sees their progress and understands the necessary adjustments will stay longer.
Personalization encompasses several realities. The most accessible is routine personalization: choosing the right combination of cleanser, serum, sunscreen, and cream, based on individual needs and goals. The most ambitious is custom formulation, produced on demand, sometimes in micro-batches, with constraints related to stability, logistics, and compliance. Between these two extremes, the most robust trend is that of modular "bases," where the in-store or digital experience allows users to adjust the intensity, texture, or active ingredients while remaining within a robust industrial framework.
In the luxury sector, AI can also enhance service, an area where excellence makes all the difference: more precise consultations, better-calibrated treatment protocols, post-treatment follow-up, and an omnichannel experience. But it also entails responsibility: protecting data, clearly defining the limitations of the diagnosis, and avoiding the illusion of medical advice. Trust will be essential for personalization.
Demanding sustainability: low-carbon packaging, water and energy at the heart of the decision-making process
The days when sustainability was limited to a "recyclable" label are over. The next decade demands industrial realism: reducing carbon footprints, integrating lower-impact materials, and considering end-of-life from the design stage. Packaging is one of the most visible areas. Lightweight glass, cosmetic-grade, aluminum, refills, deposit systems, optimized cases: each choice involves compromises between perceived luxury, safety, product compatibility, and logistical efficiency.
For premium brands, the issue is twofold. On the one hand, packaging must remain desirable, precise, and durable in the sense of being "made to last," with design elements that define the brand. On the other hand, it must align with measurable objectives, which requires life cycle assessments, qualified suppliers, and the ability to communicate progress without greenwashing. The challenge is to avoid superficial sustainability: discerning consumers quickly detect the gap between rhetoric and reality.
Beyond packaging, water resources are becoming a major focus: anhydrous or concentrated formulations, more efficient manufacturing processes, optimized industrial cleaning, and the adoption of solid formats where they make sense. Energy is managed as much in factories as in transport and storage choices. Sustainability isn't just a campaign theme; it's an engineering imperative.
Traceability and trust: from the origin of ingredients to anti-counterfeiting measures
In a globalized market, traceability is becoming a language of trust. It answers simple questions: where does the ingredient come from, how was it obtained, who processed it, and under what social and environmental conditions? Natural products, such as certain essences, plant butters, or botanical extracts, are particularly affected, but traceability also extends to synthetic or biotech ingredients, through transparency of processes and certifications.
For the luxury sector, this requirement is compounded by another challenge: counterfeiting and parallel distribution channels. Iconic serums and exceptional perfumes circulate on unauthorized platforms, posing security and reputational risks. Authentication technologies (marking, serialization, digital traceability) and efforts to control distribution channels are becoming essential. In the coming decade, authenticity will not only be a moral imperative; it will be a prerequisite for product safety.
Finally, traceability is changing the roles of different professions. Buyers, quality managers, compliance teams, packaging experts , and legal professionals are working in a more integrated way. The beauty of tomorrow is also the beauty of organization, where transparency is considered a strategic asset.
Regulation: safety, claims and transparency as drivers of innovation
Regulation is not inherently a hindrance; it is a structuring force. In cosmetics , requirements for safety, labeling, substantiating claims, and post-market surveillance directly influence how innovation occurs. Brands must substantiate their claims, define the terms used, and document tolerability. Added to this are growing expectations for transparency regarding ingredients, allergens, and certain controversial compounds.
The next decade will likely see an intensification of debates surrounding substances, microplastics, and environmental impacts. For premium brands, the decision-making process is delicate: replacing an ingredient is not simply a matter of changing a formula line; it involves reassessing stability, sensory appeal, compatibility with packaging , and sometimes even the olfactory or tactile positioning . Reformulations can become an opportunity, provided they are managed as major projects, with a clear narrative for the consumer.
In the field of AI, the regulation of data and diagnostic devices will also be crucial. Brands will need to clarify what constitutes cosmetic advice, decision support, or a more medical dimension. Compliance will be a competitive advantage, as it protects the brand and strengthens trust.
R&D, partnerships and M&A: the battle is won in the ecosystem
The innovations that will truly matter won't come from a single laboratory. They emerge from ecosystems that blend biotech startups, active ingredient suppliers, contract manufacturers, regulatory experts, data scientists, dermatologists, and research institutions. The rise of partnerships is evident: co-development of ingredients, temporary exclusivity agreements, incubation programs, and collaborations between pharmaceutical companies and technology players.
The market for acquisitions and equity investments is keeping pace with this trend. When a beauty group invests in a skin diagnostics startup or a fermentation specialist , it's buying speed, rare expertise, and sometimes a differentiated formula. Independent brands, on the other hand, can secure their growth through industrial alliances or distribution agreements that preserve their identity.
This logic has a concrete consequence: R&D is no longer just a department, it's a strategy. It involves choosing which battles to fight, protecting know-how, and orchestrating intellectual property. In the next decade of beauty, innovation will be as much a matter of governance as it is of creativity.
Supply chain and quality: robustness, deadlines and ingredient sovereignty
Recent logistical crises have made tangible what experts already knew: an innovation only exists if it can be produced, delivered, and maintained at a consistent quality. The supply chain is becoming a central issue, with concerns about the availability of raw materials, industrial capacity, transportation costs, and resilience to climate risks. For the luxury sector, which promises impeccable consistency, robustness is an absolute requirement.
Premium brands are rethinking the concept of proximity: partial relocation, supplier diversification, and increased quality control standards. The roles of quality control, formulation, and industrialization are converging, because a product's performance hinges on its execution. A remarkable ingredient is worthless if its stability is fragile, its packaging leaks, or its supply is intermittent.
